• Reported GAAP EPS of $0.54 down -50.46% YoY • Reported revenue of $373.2M up 7.88% YoY • Conmed Corp. expects full-year 2026 reported revenue between $1.345 billion and $1.375 billion, with adjusted diluted net earnings per share projected in the range of $4.30 to $4.45, including a $0.10 currency tailwind.
Bullish
Conmed Corp. achieved a 7.9% sales increase to $373.2 million, driven by strong 17.0% international revenue growth. Adjusted diluted EPS increased, supported by a strategic focus on key growth drivers.
Bearish
Conmed Corp.'s GAAP diluted EPS declined and income from operations decreased. The company also incurred significant costs related to operational optimization and product rationalization during 2025.